2023 sales growth is expected to be approximately 1%-3% over 2022, unchanged from prior guidance, consensus $12.83B.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on HSIC:
- Henry Schein (HSIC) Q2 Earnings Cheat Sheet
- Henry Schein to acquire a majority interest in Shield Healthcare, no terms
- Henry Schein acquires majority interest in Large Practice Sales LLC, no terms
- Henry Schein Medical, Medpod partner to launch Medpac
- Early notable gainers among liquid option names on June 21st